Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis

Chen Yi-Ming; Liao Tsai-Ling; Chen Hsin-Hua; Chen Der-Yuan

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis

【24h】

Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis

机译：患有类风湿性关节炎患者的三个月的一次每周一次Isoniazid Plus Rifapentine（3HP）治疗潜在结核病感染是可行的

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2018年第11期|共2页
作者
Chen Yi-Ming; Liao Tsai-Ling; Chen Hsin-Hua; Chen Der-Yuan;
展开▼
作者单位

Taichung Vet Gen Hosp Dept Med Res Taichung Taiwan;

Taichung Vet Gen Hosp Dept Med Res Taichung Taiwan;

Taichung Vet Gen Hosp Dept Med Res Taichung Taiwan;

China Med Univ Hosp Dept Med Rheumatol &

Immunol Ctr Taichung 40447 Taiwan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
入库时间 2022-08-20 01:25:01

相似文献

外文文献
中文文献
专利

1. 每周一次的紫杉烷–蒽环类联合方案与3周一次的以蒽环类为基础方案治疗r局部晚期乳腺癌的随机对照研究 [J] . Qiu-Wen Tan, Ting Luo, Hong Zheng, 癌症（英文版） . 2018,第002期
2. Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis [J] . Chen Yi-Ming, Liao Tsai-Ling, Chen Hsin-Hua, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第11期

机译：患有类风湿性关节炎患者的三个月的一次每周一次Isoniazid Plus Rifapentine（3HP）治疗潜在结核病感染是可行的
3. Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection [J] . Andrey S. Borisov, Sapna Bamrah Morris, Gibril J. Njie, Morbidity and Mortality Weekly Report: CDC Surveillance Summaries . 2018,第25期

机译：使用每周一次异烟肼-利福喷丁疗法治疗潜在结核分枝杆菌感染的建议的更新
4. Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses [J] . Christopher Pease, Brian Hutton, Fatemeh Yazdi, BMC Infectious Diseases . 2017,第1期

机译：与其他治疗潜伏性结核感染的方案相比，利福喷丁和异烟肼（3HP）的疗效和完成率：通过网络荟萃分析的系统评价
5. Mycobacterium tuberculosis Antigen-Specific IL-2R and IP-10 Expression Changes in Chronic Obstructive Pulmonary Disease Patients with in Latent Tuberculosis Infection [C] . Sungyong Bong, Sunghyun Kim, Joo Hwan Hwang, International Molecular Medicine Tri-Conference. . 2016

机译：结核分枝杆菌抗原特异性IL-2R和IP-10表达变化慢性阻塞性肺病患者潜在结核病感染
6. Treatment of latent tuberculosis infection with isoniazid (INH) for nine months versus rifampin and pyrazinamide (RZ) for two months: A comparison of rate of liver injury in Baltimore City Chest Clinic during 1999--2001. [D] . Obiako, Emmanuel Chinasa. 2007

机译：异烟肼（INH）与利福平和吡嗪酰胺（RZ）两个月治疗潜伏性肺结核感染九个月：巴尔的摩市胸科诊所1999--2001年肝损伤率的比较。
7. Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection [O] . Andrey S. Borisov, Sapna Bamrah Morris, Gibril J. Njie, 2018

机译：使用每周一次异烟肼-利福喷丁疗法治疗潜在结核分枝杆菌感染的建议的更新
8. Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine [O] . Adelaide H. McClintock, McKenna Eastment, Christy M. McKinney, 2017

机译：潜伏性结核感染的治疗完成：一项回顾性队列研究，比较了9个月的异烟肼，4个月的利福平和3个月的异烟肼和利福喷丁

Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis

著录项

相似文献

相关主题

期刊订阅